UBS Group AG - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$584,552
+2.1%
87,639
+38.7%
0.00%
Q2 2023$572,375
+136.6%
63,176
+89.8%
0.00%
Q1 2023$241,960
-67.1%
33,282
-67.0%
0.00%
Q4 2022$734,519
+265.4%
100,757
+286.7%
0.00%
Q3 2022$201,000
+161.0%
26,053
+129.9%
0.00%
Q2 2022$77,000
+450.0%
11,334
+361.7%
0.00%
Q4 2021$14,0002,4550.00%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders